High prevalence of arterial thrombosis in JAK2 mutated essential thrombocythaemia: independence of the V617F allele burden

By Larsen Thomas Stauffer   Pallisgaard Niels   Møller Michael Boe   Hasselbalch Hans Carl  

Hematology, Vol. 13, Iss. 2, 2008-04 ,pp. : 71-76

Maney Publishing

Access to resources Recommend Favorite

JAK2 haplotype 46/1 and JAK2 V617F allele burden in MPN: New evidence against the “hypermutability” hypothesis?

By  

International Journal Of Laboratory Hematology, Vol. 40, Iss. 1, 2018-02 ,pp. : e8-e10

John Wiley & Sons Inc

Access to resources Recommend Favorite

Application of PRV-1 mRNA expression level and JAK2V617F mutation for the differentiating between polycytemia vera and secondary erythrocytosis and assessment of treatment by interferon or hydroxyurea

By Tutaeva V.   Misurin A. V.   Michiels J. J.   Rozenberg J. M.   Sokolova M. A.   Ivanova V. L.   Kolosheinova T. I.   Manakova T. E.   Levina A. A.   Semenova E. A.   Khoroshko N. D.  

Hematology, Vol. 12, Iss. 6, 2007-12 ,pp. : 473-479

Maney Publishing

Access to resources Recommend Favorite

JAK2 46/1 haplotype is associated with JAK2 V617F – positive myeloproliferative neoplasms in Brazilian patients

By  

International Journal Of Laboratory Hematology, Vol. 37, Iss. 5, 2015-10 ,pp. : 654-660

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reemergence of JAK2 V617F clone heralds extramedullary leukemia relapse after BMT for transformed essential thrombocytosis

By Au W.   Fung A.   Lie A.   Lam K.   Lam C.   Kwong Y.  

Annals of Hematology, Vol. 86, Iss. 2, 2007-02 ,pp. : 145-147

Springer Publishing Company

Access to resources Recommend Favorite